Thai Scales for Outcomes in Parkinson’s Disease-Nighttime Sleep and Modified Parkinson’s Disease Sleep Scale for Assessment of Nighttime Sleep Disorder Compared with Pittsburgh Sleep Quality Index at the Faculty of Medicine Vajira Hospital
Journal Title: Vajira Medical Journal: Journal of Urban Medicine - Year 2021, Vol 65, Issue 1
Abstract
Objectives: This study aimed to evaluate the sensitivity and specificity of the Thai versions of Scales for Outcomes in Parkinson’s Disease-Nighttime Sleep (SCOPA-NS) and Modified Parkinson’s Disease Sleep Scale (MPDSS) test for patients with Parkinson’s disease in comparison with the Pittsburgh Sleep Quality Index (PSQI) test. Methods: This cross-sectional study enrolled patients with Parkinson’s disease who sought treatment at the OPD department, Division of Neurology, Faculty of Medicine Vajira Hospital. The study was conducted from 1 March 2019 to 31 December 2019. Volunteers completed Thai SCOPA-NS and MPDSS sleep tests to obtain the sensitivity and specificity of each test, which was then compared with the PSQI test. Results: Of the 216 volunteers, 200 met the study criteria. To evaluate nighttime sleep, SCOPA-NS test and MPDSS test in Thai language were used. The prevalence rates of sleep disorders in volunteers using the SCOPA-NS test and MPDSS test were 62.5% (95% confidence interval [CI] 55.4–69.2) and 52.5% (95% CI 45.3–59.6), respectively. Youden’s index (1− (sensitivity + specificity)) was used to find the optimal cut-off points by comparing it with the PSQI test. SCOPA-NS test has a sensitivity of 83.1% (95%CI 75.3–89.2), specificity of 71.1% (95% CI 59.5–80.9), positive predictive value (PPV) of 82.4% (95% CI 74.6–88.6), and negative predictive value (NPV) of 72% (95% CI 60.4–81.8), whereas the MPDSS test has a sensitivity of 71.8% (95% CI 63.0–79.5), specificity of 78.9% (95% CI 68.1–87.5), PPV of 84.8% (95% CI 76.4–91.0), and NPV of 63.2% (95% CI 52.6–72.8). The volunteers preferred doing the SCOPA-NS test than the MPDSS test with preference rates of 65.5% and 34.5%, respectively. Conclusion: Thai SCOPA-NS test has higher sensitivity but lower specificity than the MPDSS test. However, patients significantly prefer doing the Thai SCOPA-NS test than the MPDSS test. Both tests can be used to evaluate patients with Parkinson’s disease at comparable accuracy. However, Thai SCOPA-NS test took shorter test, and patients with Parkinson’s disease prefer this test. We recommend using Thai SCOPA-NS in screening for sleep disorder in this patient population.
Authors and Affiliations
Sirinapa Saneemanomai, Suwat Srisuwannanukorn
Keywords
Related Articles
- EP ID EP723303
- DOI http://dx.doi.org/10.14456/vmj.2021.5
- Views 48
- Downloads 0
A comparison of laparoscopic versus open appendectomy for overweight patients in Bangkok Metropolitan Administration General Hospital: a retrospective study
Objectives: To compare the result of appendicitis treatment between laparoscopic surgery (LA) and open surgery (OA) in overweight patient. In term of hospital length of stay (LOS), intraoperative time, time to resume die...
The Prevalence and Pregnancy Outcomes of Short Cervix in Low Risk Singleton Pregnancy from Universal Cervical Length Screening
Objective: To study the prevalence of short cervix in low risk singleton pregnancy. Methods: A retrospective descriptive study was conducted in 1099 low risk singleton pregnant women who came for antenatal care at 16-2...
The Association between Parenting Styles and Behavioral Problems in Children
Background: Behavioral problem was the common problem that had long-term effects on child’s performance. This study aimed to investigate the association between parenting style and child behavioral problems. Methods: A...
Preventive Dentistry in Children with Special Needs: Narrative Review
Children with special healthcare needs face a high prevalence of dental and oral health problems due to unique challenges in maintaining oral hygiene. Preventive dentistry, which encompasses practices and strategies aime...
Prosperity of celecoxib for pain relief after elective cesarean delivery, a double-blind randomized controlled trial
Objective: To determine the effectiveness of 400-mg celecoxib after elective cesarean delivery. Methods: In this randomized double blinded controlled trial, 110 full-term pregnant women aged between 20-40 years old who...